All Stories

  1. Cross-sectional and longitudinal associations between glycaemic measures and grip strength in people without diabetes in the UK Biobank cohort study
  2. Nutrition in the prevention and treatment of skeletal muscle ageing and sarcopenia: a single nutrient, a whole food and a whole diet approach
  3. Identifying combinations of long-term conditions associated with sarcopenia: a cross-sectional decision tree analysis in the UK Biobank study
  4. Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men
  5. The prevalence of sarcopenia in Parkinson’s disease and related disorders- a systematic review
  6. Determining the feasibility of characterising cellular senescence in human skeletal muscle and exploring associations with muscle morphology and physical function at different ages: findings from the MASS_Lifecourse Study
  7. New Horizons in cellular senescence for clinicians
  8. Milk intake across adulthood and muscle strength decline from mid- to late life: the MRC National Survey of Health and Development
  9. Immunosenescence profiles are not associated with muscle strength, physical performance and sarcopenia risk in very old adults: The Newcastle 85+ Study
  10. Feasibility and acceptability of a milk and resistance exercise intervention to improve muscle function in community-dwelling older adults (MIlkMAN): Pilot study
  11. <p>Milk for Skeletal Muscle Health and Sarcopenia in Older Adults: A Narrative Review</p>
  12. Effects of dietary patterns and low protein intake on sarcopenia risk in the very old: The Newcastle 85+ study
  13. Study of the Older Adults’ Motivators and Barriers Engaging in a Nutrition and Resistance Exercise Intervention for Sarcopenia: An Embedded Qualitative Project in the MIlkMAN Pilot Study
  14. Sarcopenia, long‐term conditions, and multimorbidity: findings from UK Biobank participants
  15. Mediterranean diet adherence and cognitive function in older UK adults: the European Prospective Investigation into Cancer and Nutrition–Norfolk (EPIC-Norfolk) Study
  16. Milk and resistance exercise intervention to improve muscle function in community-dwelling older adults at risk of sarcopenia (MIlkMAN): protocol for a pilot study
  17. Factors associated with change in self-reported physical activity in the very old: The Newcastle 85+ study
  18. Contribution of protein intake and its interaction with physical activity to transitions between disability states and to death in very old adults: the Newcastle 85+ Study
  19. Dietary Patterns, Skeletal Muscle Health, and Sarcopenia in Older Adults
  20. The recent secular trend in grip strength among older adults: findings from the English Longitudinal Study of Ageing
  21. Low protein intake, muscle strength and physical performance in the very old: The Newcastle 85+ Study
  22. Protein Intake and Disability Trajectories in Very Old Adults: The Newcastle 85+ Study
  23. Mitochondrial respiratory chain function and content are preserved in the skeletal muscle of active very old men and women
  24. Plasma Vitamin B12, Supplementation and Mortality
  25. Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations
  26. Nutrition in the Very Old
  27. Elevated Total Homocysteine in All Participants and Plasma Vitamin B12 Concentrations in Women Are Associated With All-Cause and Cardiovascular Mortality in the Very Old: The Newcastle 85+ Study
  28. Factors Associated With Physical Performance Measures in a Multiethnic Cohort of Older Adults
  29. Vitamin D and Ageing
  30. Homocysteine, Tryptophan, and Cognition in the Very Old
  31. Prevalence and determinants of low protein intake in very old adults: insights from the Newcastle 85+ Study
  32. One-Carbon Metabolism Biomarkers and Cognitive Decline in the Very Old: The Newcastle 85+ Study
  33. [P2–140]: ABNORMAL CHROMOSOME COPY NUMBER AND ASSOCIATED NEURONAL CELL DEATH IN FRONTOTEMPORAL LOBAR DEGENERATION
  34. Mitochondrial respiratory chain deficiency in older men and its relationship with muscle mass and performance
  35. Longitudinal changes in global and domain specific cognitive function in the very-old: findings from the Newcastle 85+ Study
  36. Grip strength and inflammatory biomarker profiles in very old adults
  37. Initial level and rate of change in grip strength predict all-cause mortality in very old adults
  38. Vitamin D Status, Muscle Strength and Physical Performance Decline in Very Old Adults: A Prospective Study
  39. Association of mitochondrial respiratory chain deficiency in older men with muscle mass and physical performance: findings from the Hertfordshire Sarcopenia Study
  40. Using Fluorescence In Situ Hybridization (FISH) Analysis to Measure Chromosome Instability and Mosaic Aneuploidy in Neurodegenerative Diseases
  41. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study
  42. Predicting Risk of Cognitive Decline in Very Old Adults Using Three Models: The Framingham Stroke Risk Profile; the Cardiovascular Risk Factors, Aging, and Dementia Model; and Oxi-Inflammatory Biomarkers
  43. Grip Strength Decline and Its Determinants in the Very Old: Longitudinal Findings from the Newcastle 85+ Study
  44. Micronutrient intake and food sources in the very old: analysis of the Newcastle 85+ Study
  45. What do we know about the nutritional status of the very old? Insights from three cohorts of advanced age from the UK and New Zealand
  46. Macronutrient intake and food sources in the very old: analysis of the Newcastle 85+ Study
  47. Effect of Dietary Patterns on Muscle Strength and Physical Performance in the Very Old: Findings from the Newcastle 85+ Study
  48. Dietary patterns and cognitive functioning in very old adults
  49. Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
  50. Dietary Patterns and Socioeconomic Status in the Very Old: The Newcastle 85+ Study
  51. Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study
  52. Antihypertensive drug use and risk of cognitive decline in the very old
  53. Is There an Association Between Metabolic Syndrome and Cognitive Function in Very Old Adults? The Newcastle 85+ Study
  54. Serum 25‐hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study
  55. P2‐011: Aβ INHIBITION OF KINESIN 5 DISRUPTS THE LOCALIZATION AND FUNCTION OF MEMBRANE PROTEINS: IMPLICATIONS FOR NEURONAL RESPONSES TO NEUROTROPHINS, NEUROTRANSMITTERS, GLUCOSE, AND LIPIDS IN AD
  56. 25‐hydroxyvitamin D and increased all‐cause mortality in very old women: the Newcastle 85+ study
  57. P1–118: Frontemporal dementia mutations in MAPT cause chromosome mis‐segregation and aneuploidy including trisomy 21
  58. Mitotic Spindle Defects and Chromosome Mis-Segregation Induced by LDL/Cholesterol—Implications for Niemann-Pick C1, Alzheimer’s Disease, and Atherosclerosis
  59. Midlife dietary patterns and mortality in the population-based study of Swedish twins
  60. P3‐036: Aß inhibition of kinesin 5 induces neurotransmitter and neurotrophin receptor mislocalization and dysfunction
  61. P2‐085: Genomic damage induced by lipoproteins/cholesterol: Implications for Alzheimer's and cardiovascular disease
  62. Down Syndrome Model of Alzheimer’s Disease: Beyond Trisomy 21Nondisjunction
  63. P4‐324: Aβ inhibits specific kinesin motors involved in both mitosis and neuronal function; potential implications for neurogenesis and neuroplasticity in Alzheimer's disease and Down syndrome
  64. Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors
  65. Everyday reasoning abilities in persons with Parkinson's disease
  66. P4‐005: Alzheimer Aβ Induces Chromosome Mis‐segregation, Microtubule Defects, Receptor Mis‐localization, and Inhibition of Mitotic/Neuronal Kinesins: Implications for Neurogenesis and Plasticity in Neurodegenrative Diseases
  67. Alzheimer Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for Tau and APP
  68. P1‐432: Alzheimer's mutant presenilin‐1 and amyloid precursor protein genes cause chromosome missegregation and aneuploidy through the action of Abeta peptide
  69. P3‐315: Inhibition of gamma‐secretase activity induces cell cycle defects and chromosome missegregation
  70. P4‐302: Lipoprotein‐induced chromosome missegregation in vitro and in vivo: Implications for cardiovascular and Alzheimer's disease
  71. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy
  72. P3–227: Chromosome aneuploidy, including human trisomy 21 caused by Alzheimer's mutant presenilin 1/ Î3–secretase
  73. P4-293 The presenilins, chromosome missegregation, and Alzheimer's disease